13D/13G Filings - StemPoint Capital LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-14
1:03 pm
Purchase
2024-12-3113GSurrozen, Inc.
SRZN
StemPoint Capital LP485,231
14.300%
57,455increase
(+13.43%)
Filing
History
2025-02-14
1:01 pm
Purchase
2024-12-3113GVistaGen Therapeutics, Inc.
VTGN
StemPoint Capital LP2,328,492
8.200%
538,310increase
(+30.07%)
Filing
History
2024-11-01
12:42 pm
Purchase
2024-10-3113GSurrozen, Inc.
SRZN
StemPoint Capital LP427,776
12.800%
427,776increase
(New Position)
Filing
History
2024-02-12
6:27 pm
Purchase
2023-12-3113GVistaGen Therapeutics, Inc.
VTGN
StemPoint Capital LP1,790,182
6.500%
1,790,182increase
(New Position)
Filing
History